Drug Profile
Research programme: anti-parathyroid hormone antagonists - Biotecnol/Universite Louis Pasteur/Strasbourg University
Latest Information Update: 14 Jun 2012
Price :
$50
*
At a glance
- Originator Biotecnol Inc.; Universite Louis Pasteur de Strasbourg
- Developer Biotecnol Inc.; University of Strasbourg
- Class Antibodies
- Mechanism of Action Apoptosis stimulants; Parathyroid hormone receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Renal cancer